MonaLiza Medical Overview

  • Founded
  • 2003
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $3M
Latest Deal Amount
  • Investors
  • 2

MonaLiza Medical General Information

Description

Developer of a genetic test kit designed to conduct prenatal genetic screening in transcervical cell samples extracted during the first trimester of pregnancy. The company's kit identifies and checks embryo cells at an early stage of pregnancy to identify the sex of babies, enabling parents to know the gender of the foetus at an early stage.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • Petah Tiqwa 49170
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MonaLiza Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 29-Jul-2004 $3M 000 Completed Startup
To view MonaLiza Medical’s complete valuation and funding history, request access »

MonaLiza Medical Executive Team (2)

Name Title Board Seat Contact Info
Moshe Fejgin MD Co-Founder & Chief Executive Officer
Aliza Amiel Co-Founder
To view MonaLiza Medical’s complete executive team members history, request access »

MonaLiza Medical Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Delta Ventures Venture Capital Minority 000 0000 000000 0
Israel Healthcare Ventures Venture Capital Minority 000 0000 000000 0
To view MonaLiza Medical’s complete investors history, request access »